Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
77°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atyr Pharma Inc
(NQ:
LIFE
)
1.900
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Atyr Pharma Inc
< Previous
1
2
3
4
Next >
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
June 05, 2024
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real.
Via
InvestorPlace
LIFE Stock Earnings: aTyr Pharma Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
LIFE stock results show that aTyr Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while.
Via
InvestorPlace
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023
March 14, 2024
LIFE stock results show that aTyr Pharma missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Recap: aTyr Pharma Q4 Earnings
March 14, 2024
Via
Benzinga
aTyr Pharma's Earnings Outlook
March 13, 2024
Via
Benzinga
Analyst Expectations for aTyr Pharma's Future
September 21, 2023
Via
Benzinga
The Latest Analyst Ratings for aTyr Pharma
May 23, 2023
Via
Benzinga
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
aTyr Pharma: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Where aTyr Pharma Stands With Analysts
March 10, 2023
Via
Benzinga
aTyr Pharma's Earnings: A Preview
March 08, 2023
Via
Benzinga
The 3 Best Penny Stocks to Buy in February 2024
February 15, 2024
With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies.
Via
InvestorPlace
$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
August 02, 2023
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks...
Via
Benzinga
aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst
July 05, 2023
Oppenheimer has downgraded aTyr Pharma Inc (NASDAQ: LIFE) to Perform from Outperform, citing a few material catalysts in the next few quarters.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023
July 05, 2023
Via
Benzinga
7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023
June 28, 2023
Bard AI has consistently outperformed, and it has identified seven growth stocks that it believes will deliver triple-digit returns.
Via
InvestorPlace
3 Stocks and Cryptos With the Highest Potential Returns
May 07, 2023
If you're only worried about upside, these stocks and cryptos have some of the highest possible returns in the market.
Via
InvestorPlace
7 Hot Growth Stocks Poised to Triple in 2023
May 05, 2023
These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher.
Via
InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 09, 2023
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Via
Benzinga
This Company Is Beginning A Pivotal Phase 3 EFZO-FIT™ Study. Could It Be A Much-Needed Treatment For Pulmonary Sarcoidosis?
November 29, 2022
Most people may never have heard of sarcoidosis, an inflammatory disease that affects about 1.2 million people worldwide.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 18, 2022
On Friday, 64 companies achieved new lows for the year.
Via
Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via
Benzinga
aTyr Pharma Gets FDA Fast Track Status For Systemic Sclerosis Candidate
September 13, 2022
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod, for the treatment of systemic sclerosis...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 13, 2022
Via
Benzinga
NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks
August 16, 2022
Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.